We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENVX icon
601
CALL
Enovix
ENVX
$1.05B
– –
-34,743
Closed -$18.4K
EOSEW
602
Eos Energy Enterprises Warrant
EOSEW
$31.1M
– –
-249,756
Closed -$60.1K
EVLVW
603
DELISTED
Evolv Technologies Warrant
EVLVW
– –
-128,688
Closed -$55K
EWT icon
604
iShares MSCI Taiwan ETF
EWT
$11.2B
– –
-74,193
Closed -$2.98M
EXAS
605
CALL
DELISTED
Exact Sciences
EXAS
– –
-36,000
Closed -$68.4K
EXAS
606
DELISTED
Exact Sciences
EXAS
– –
-22,514
Closed -$1.11M
EXAS
607
PUT
DELISTED
Exact Sciences
EXAS
– –
-23,400
Closed -$50.3K
FATE icon
608
Fate Therapeutics
FATE
$319M
– –
-15,000
Closed -$151K
FHN icon
609
First Horizon
FHN
$12B
– –
-35,949
Closed -$881K
FHN icon
610
PUT
First Horizon
FHN
$12B
– –
-1,100
Closed -$192
FITB
611
CALL
Fifth Third Bancorp
FITB
$52.2B
– –
-101,000
Closed -$35.4K
FITB
612
Fifth Third Bancorp
FITB
$52.2B
– –
-15,265
Closed -$501K
FOLD
613
CALL
DELISTED
Amicus Therapeutics
FOLD
– –
-7,600
Closed -$12.5K
FOLD
614
DELISTED
Amicus Therapeutics
FOLD
– –
-13,001
Closed -$159K
FOLD
615
PUT
DELISTED
Amicus Therapeutics
FOLD
– –
-5,000
Closed -$1.25K
GB
616
DELISTED
Global Blue Group Holding
GB
– –
-11,919
Closed -$55.2K
GB.WS
617
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
– –
-34,337
Closed -$10.7K
GBTG icon
618
American Express Global Business Travel
GBTG
$4.93B
– –
-11,458
Closed -$77.3K
GDS icon
619
CALL
GDS Holdings
GDS
$6.54B
– –
-14,600
Closed -$2.92K
GH icon
620
CALL
Guardant Health
GH
$22.2B
– –
-4,800
Closed -$1.8K
GH icon
621
Guardant Health
GH
$22.2B
– –
-4,819
Closed -$131K
GH icon
622
PUT
Guardant Health
GH
$22.2B
– –
-4,800
Closed -$109K
GRRRW
623
Gorilla Technology Group Warrant
GRRRW
$1.79M
– –
-51,904
Closed -$10.6K
HAL icon
624
Halliburton
HAL
$28.2B
– –
-32,210
Closed -$1.27M
HAL icon
625
PUT
Halliburton
HAL
$28.2B
– –
-64,400
Closed -$2.42K
23 24
25
26 27

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.